Driehaus Capital Management’s Calidi Biotherapeutics CLDI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-789
| Closed | -$18.9K | – | 394 |
|
|
2024
Q2 | $18.9K | Hold |
789
| – | – | ﹤0.01% | 361 |
|
|
2024
Q1 | $53.5K | Hold |
789
| – | – | ﹤0.01% | 378 |
|
|
2023
Q4 | $143K | Hold |
789
| – | – | ﹤0.01% | 377 |
|
|
2023
Q3 | $360K | Buy |
789
+221
| +39% | +$101K | ﹤0.01% | 361 |
|
|
2023
Q2 | $715K | Hold |
568
| – | – | 0.01% | 323 |
|
|
2023
Q1 | $700K | Hold |
568
| – | – | 0.01% | 335 |
|
|
2022
Q4 | $693K | Sell |
568
-7,765
| -93% | -$9.47M | 0.01% | 307 |
|
|
2022
Q3 | $9.85M | Sell |
8,333
-4,167
| -33% | -$4.93M | 0.15% | 193 |
|
|
2022
Q2 | $14.9M | Hold |
12,500
| – | – | 0.24% | 142 |
|
|
2022
Q1 | $14.8M | Hold |
12,500
| – | – | 0.18% | 175 |
|
|
2021
Q4 | $14.7M | Buy |
+12,500
| New | +$14.7M | 0.15% | 192 |
|